Revolutionizing Precision Medicine with the Power of AI and Metabolites
Why Metabolites
Metabolites are small molecules like glucose & cholesterol that are produced during metabolic processes.
- They direct readouts of both genetic & non-genetic factors associated with disease and drug response.
- Metabolites are secreted to the blood from normal tissues and disease cells.
- The study of <200 blood metabolites in >117,000 individuals predicted multi-disease outcomes. (Nature Medicine, 28, 2022, 2309–2320)
Our patented AI-based platform overcomes critical challenges in large-scale metabolomics, such as signal detection and annotation within a multi-omics context.
This innovation enables first-in-class generative models and metabolic twins, virtual patients that simulate health, disease, and treatment response.
How does our technology work?
Precision Obesity
Metabolic health is currently assessed using oversimplified metrics like BMI, fasting glucose, or limited lipid panels.
We use AI and 10,000+ lipids and metabolites to develop digital metabolic twins.
Our obesity twins predict metabolic health beyond BMI and risk of T2D, CVD, and other chronic diseases.
Partner with us
We believe in the power of partnerships to bring the right treatment for the right patients faster
Label/indication expansion
By utilizing multi-modal metabolomics data, we identify additional patient populations that could benefit from the drug
Optimized clinical trial design
Our virtual patients simulate placebo arms to reduce clinical trial size and predict treatment responders to improve success rates.
Therapeutic development
Our platform identifies and prioritizes novel targets, driving combination strategies and portfolio optimization.
Contact us
ADDRESS:
ReviveMed Inc
245 First St.,
Cambridge, MA, 02142
Follow us on: